SLC6A3 and Parkinson disease: The substantia nigra area on neuromelanin-sensitive MRI appears to be directly correlated with dopamine transporter density on SPECT neuroimaging, suggesting that neuromelanin-MRI may be a potential biomarker to quantify substantia nigra pathology and dopaminergic loss in PD.44